Human Immunodeficiency Virus (HIV) Screen by EIA

TEST NAME Human Immunodeficiency Virus Screen 
DISORDER/DISEASE Human Immunodeficiency Virus

Testing not approved for patients < 2 years of age

Positive HIV screening tests are reflexed to the Geenius HIV 1/2 Supplemental Assay for confirmation.  HIV-2 antibody confirmation has not been verified with this assay.  If HIV-2 results are needed, please contact the laboratory for routing to CDC for confirmation.



Test Order Code:  87389

Test Order Description: HIV EIA SCREEN


TDH DLS Requisition:  PH-4182 Clinical Submission Requisition Form

Specimen Requirements

Patient Preparation
  • Venipuncture
Specimen Collection
  • Acceptable Specimen Sources/Type(s):

-  Whole blood in serum separator tube (SST)

-  Serum in sterile, plastic, screw capped vial

Specimen Labeling
  • Specimen should be labeled with at least two unique patient identifiers and match accompanying test order.
Specimen Processing
  • Follow the tube manufacture's processing instructions for collection tubes.
Specimen Storage and Preservation
  • Specimens may be stored on or off the clot, red blood cells, or separator gel for:

- Up to 72 hours post collection at 2 - 30°C or

- Up to seven (7) days at 2 - 8 °C

  • If testing will be delayed more than three (3) days for specimens stored at room temperature or more than seven (7) days for specimens stored at 2 - 8°C, aliquot serum and store at (-20)°C or colder.
  • Avoid three (3) or more freeze/thaw cycles.
Specimen Transportation 
  • Ship specimens at 2-8°C on cold packs, if possible. Specimens may be shipped at 2-30°C if receipt at the laboratory will occur within 72 hours of collection.
  • Specimen must be placed in an individual biohazard bag with absorbent material and should be shipped to the laboratory on the day of collection. 
  • All infectious substance shipments must conform to U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR 49 C.F.R. Parts 171-180). 
Specimen Acceptability and Rejection
  • Specimen from patients <2 years old will be rejected. 
Testing Location
  • Nashville
  • Knoxville

This Page Last Updated: April 11, 2024 at 11:38 AM